Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
170M
-
Number of holders
-
179
-
Total 13F shares, excl. options
-
68.1M
-
Shares change
-
+10.8M
-
Total reported value, excl. options
-
$2.62B
-
Value change
-
+$461M
-
Put/Call ratio
-
2.47
-
Number of buys
-
119
-
Number of sells
-
-68
-
Price
-
$38.39
Significant Holders of Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) as of Q3 2023
236 filings reported holding IMVT - Immunovant, Inc. - Common Stock, par value $0.0001 per share as of Q3 2023.
Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) has 179 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 68.1M shares
of 170M outstanding shares and own 40.11% of the company stock.
Largest 10 shareholders include FMR LLC (7.75M shares), VANGUARD GROUP INC (6.23M shares), BlackRock Inc. (4.13M shares), PERCEPTIVE ADVISORS LLC (3.81M shares), STATE STREET CORP (3.47M shares), Deep Track Capital, LP (2.8M shares), Darwin Global Management, Ltd. (1.82M shares), Logos Global Management LP (1.6M shares), Alpine Global Management, LLC (1.25M shares), and Alpine Global Management, LLC (1.25M shares).
This table shows the top 179 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.